# Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

> **NCT05029583** · NA · UNKNOWN · sponsor: **LMC Diabetes & Endocrinology Ltd.** · enrollment: 5000 (estimated)

## Conditions studied

- Nonalcoholic Steatohepatitis
- Type 2 Diabetes

## Interventions

- **OTHER:** routine screening
- **OTHER:** physician-driven screening

## Key facts

- **NCT ID:** NCT05029583
- **Lead sponsor:** LMC Diabetes & Endocrinology Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-11
- **Primary completion:** 2025-10-05
- **Final completion:** 2025-10-05
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05029583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05029583, "Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05029583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*